APA (7th ed.) Citation

Das, N., Banavali, S., Bakhshi, S., Trehan, A., Radhakrishnan, V., Seth, R., . . . Krishnan, S. (2022). Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): A prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India. BMC.

Chicago Style (17th ed.) Citation

Das, Nandana, et al. Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): A Prospective, Risk Stratified, Randomised, Multicentre, Open Label, Controlled Therapeutic Trial for Newly Diagnosed Childhood Acute Lymphoblastic Leukaemia in India. BMC, 2022.

MLA (9th ed.) Citation

Das, Nandana, et al. Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): A Prospective, Risk Stratified, Randomised, Multicentre, Open Label, Controlled Therapeutic Trial for Newly Diagnosed Childhood Acute Lymphoblastic Leukaemia in India. BMC, 2022.